SecBot SecBot

SNOA

Sonoma Pharmaceuticals, Inc.
Nasdaq· Surgical & Medical Instruments & Apparatus· Inc. DE· CIK 0001367083 Biotech & Drug Discovery
$1.15 +0.03 (+2.68%)
Oct 27 4:00 PM ET · prev $1.12
Market cap
$5.3M
Nano cap
Median target
$12.00
+943% · range $12.00–12.00
Next earnings
Nov 2
in 6 days
1 year
−71.3%
from $4.00 · Oct 27
30 days
−8.7%
from $1.26
52-week range
$1.01–4.00
−71% from high · low May 19
Avg volume 20D
41.0K
Sep 30 spike 110.7K
Short interest
🔒 Subscribers only
Insider net
$0
no open-market trades · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
6
analyzed by SecBot
SecBot read MIXED 1 report · 90 days
Balance 0 bearish · 0 bullish · 1 neutral oldest → newest, height = score
Avg score ·High conf. 1/1 ·Next Earnings date, Nov 2, 2026
Strongest NEUTRAL Sonoma Pharmaceuticals adopted a new Section 382 shareholder rights plan (poison pill) effective October 6…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersNO TRADES

    No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.

  • InstitutionsMIXED

    Q2 2026: 2 added (0 new), 0 trimmed or exited.

  • TrendDOWNTREND

    8% below its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
GEODE CAPITAL MANAGEMENT, LLCADD26,787$32.9K
UBS Group AGDOUBLED7,808$9.6K
GEODE CAPITAL MANAGEMENT, LLCADD19,941$42.5K
MORGAN STANLEYDOUBLED2,004$4.3K
UBS Group AGNEAR_EXIT6$22.00
UBS Group AGNEAR_EXIT108$419.00
UBS Group AGDOUBLED14,417$41.0K
UBS Group AGNEAR_EXIT1,852$4.1K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

last action Sep 2023
12-month targets · 1 analysts

Price is below the lowest target. Median implies +943%.Targets as of May 20, 2026.

Recent actions
DateFirmActionRating
Sep 5, 2023Ladenburg Thalmann
INITIATE
INITIATEBuy
Mar 6, 2018Maxim Group
DOWNGRADE
DOWNGRADEHold
Dec 28, 2017Benchmark
INITIATE
INITIATESpeculative Buy
Nov 10, 2017Maxim Group
MAINTAIN
MAINTAINBuy

Insider ledger

Form 4
$0
open-market buys or sells · 12 mo
DateInsiderTypeValue
Jul 9, 2026
Weigerstorfer Philippe
Director
AWARD10,000 sh
Jul 9, 2026
MCLAUGHLIN JOHN
Director
AWARD10,000 sh
Jul 9, 2026
Trombly Amy Moss
Chief Executive Officer
AWARD10,000 sh
Jul 9, 2026
Jacoby Vanessa
Director
AWARD10,000 sh
Jul 9, 2026
DVONCH JEROME J
Chief Financial Officer
AWARD10,000 sh
Jul 9, 2026
Dal Poggetto John
Controller
AWARD7,500 sh

Earnings setup

Estimates
Nov 2
reports in 6 days
PeriodEPS est.Range30D rev.Revenue
Current Q———$0.00
Next Q———$0.00
Current FY———$0.00
Next FY———$0.00

Short side

FINRA· Oct 15, 2026
🔒 Subscribers only
shares short
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 6, 2026 SEC
Sonoma Pharmaceuticals adopted a new Section 382 shareholder rights plan (poison pill) effective October 6, 2026…
8-K — Impact 3/10
Aug 5, 2026 Earnings calendar
SNOA Q1 2027 Earnings Scheduled — 2026-08-05
Jul 9, 2026 Insider
Weigerstorfer Philippe was granted 10,000 shares
Director
Jul 9, 2026 Insider
MCLAUGHLIN JOHN was granted 10,000 shares
Director
Jul 9, 2026 Insider
Trombly Amy Moss was granted 10,000 shares
Chief Executive Officer
Jun 30, 2026 Inst.
GEODE CAPITAL MANAGEMENT, LLC — ADD
26,787 shares ($32.9K)
Jun 30, 2026 Inst.
UBS Group AG — DOUBLED
7,808 shares ($9.6K)
Jun 18, 2026 SEC
Sonoma Pharmaceuticals filed an 8-K to update the maximum offering amount under its existing at-the-market (ATM)…
8-K — Impact 6/10
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 2, 2026
Earnings date
SNOA Q2 2027 Earnings Scheduled — 2026-11-02
Recent
Aug 5, 2026
Earnings date
SNOA Q1 2027 Earnings Scheduled — 2026-08-05
Jun 15, 2026
Earnings date
SNOA Q4 2026 Earnings After Market Close — 2026-06-15
Apr 30, 2026
Short interest
FTD: SNOA — 903,191 shares ($1.0M) failed to deliver
Settlement: 20260430, Price: $1.06, FTD Value: $957,382.46, SONOMA PHARMACEUTICALS INC COM
Apr 29, 2026
Short interest
FTD: SNOA — 840,284 shares ($0.9M) failed to deliver
Settlement: 20260429, Price: $1.04, FTD Value: $873,895.36, SONOMA PHARMACEUTICALS INC COM
Apr 28, 2026
Short interest
FTD: SNOA — 830,856 shares ($0.9M) failed to deliver
Settlement: 20260428, Price: $1.11, FTD Value: $922,250.16, SONOMA PHARMACEUTICALS INC COM

SecBot reports

6 filings · 0 bullish · 3 bearish · 3 neutral
All SNOA filing & press-release reports (6)